<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d32" origId="Furosemide"><sentence id="DrugDDI.d32.s0" origId="s0" text="Furosemide may increase the ototoxic potential of aminoglycoside antibiotics, especially in the presence of impaired renal function."><entity id="DrugDDI.d32.s0.e0" origId="s0.p0" charOffset="0-10" type="drug" text="Furosemide"/><entity id="DrugDDI.d32.s0.e1" origId="s0.p4" charOffset="50-76" type="drug" text="aminoglycoside antibiotics"/><pair id="DrugDDI.d32.s0.p0" e1="DrugDDI.d32.s0.e0" e2="DrugDDI.d32.s0.e1" interaction="true"/></sentence><sentence id="DrugDDI.d32.s1" origId="s1" text="Except in life-threatening situations, avoid this combination."/><sentence id="DrugDDI.d32.s2" origId="s2" text="Furosemide should not be used concomitantly with ethacrynic acid because of the possibility of ototoxicity."><entity id="DrugDDI.d32.s2.e0" origId="s2.p12" charOffset="0-10" type="drug" text="Furosemide"/><entity id="DrugDDI.d32.s2.e1" origId="s2.p18" charOffset="49-65" type="drug" text="ethacrynic acid"/><pair id="DrugDDI.d32.s2.p0" e1="DrugDDI.d32.s2.e0" e2="DrugDDI.d32.s2.e1" interaction="true"/></sentence><sentence id="DrugDDI.d32.s3" origId="s3" text="Patients receiving high doses of salicylates concomitantly with furosemide, as in rheumatic disease, may experience salicylate toxicity at lower doses because of competitive renal excretory sites."><entity id="DrugDDI.d32.s3.e0" origId="s3.p24" charOffset="33-44" type="drug" text="salicylates"/><entity id="DrugDDI.d32.s3.e1" origId="s3.p25" charOffset="64-75" type="drug" text="furosemide"/><pair id="DrugDDI.d32.s3.p0" e1="DrugDDI.d32.s3.e0" e2="DrugDDI.d32.s3.e1" interaction="true"/></sentence><sentence id="DrugDDI.d32.s4" origId="s4" text="Furosemide has a tendency to antagonize the skeletal muscle relaxing effect of tubocurarine and may potentiate the action of succinylcholine."><entity id="DrugDDI.d32.s4.e0" origId="s4.p33" charOffset="0-10" type="drug" text="Furosemide"/><entity id="DrugDDI.d32.s4.e1" origId="s4.p38" charOffset="79-91" type="drug" text="tubocurarine"/><entity id="DrugDDI.d32.s4.e2" origId="s4.p43" charOffset="125-140" type="drug" text="succinylcholine"/><pair id="DrugDDI.d32.s4.p0" e1="DrugDDI.d32.s4.e0" e2="DrugDDI.d32.s4.e1" interaction="true"/><pair id="DrugDDI.d32.s4.p1" e1="DrugDDI.d32.s4.e0" e2="DrugDDI.d32.s4.e2" interaction="false"/><pair id="DrugDDI.d32.s4.p2" e1="DrugDDI.d32.s4.e1" e2="DrugDDI.d32.s4.e2" interaction="false"/></sentence><sentence id="DrugDDI.d32.s5" origId="s5" text="Lithium generally should not be given with diuretics because they reduce lithiums renal clearance and add a high risk of lithium toxicity."><entity id="DrugDDI.d32.s5.e0" origId="s5.p44" charOffset="0-7" type="drug" text="Lithium"/><entity id="DrugDDI.d32.s5.e1" origId="s5.p49" charOffset="43-52" type="drug" text="diuretics"/><entity id="DrugDDI.d32.s5.e2" origId="s5.p53" charOffset="73-80" type="drug" text="lithium"/><pair id="DrugDDI.d32.s5.p0" e1="DrugDDI.d32.s5.e0" e2="DrugDDI.d32.s5.e1" interaction="true"/><pair id="DrugDDI.d32.s5.p1" e1="DrugDDI.d32.s5.e0" e2="DrugDDI.d32.s5.e2" interaction="false"/><pair id="DrugDDI.d32.s5.p2" e1="DrugDDI.d32.s5.e1" e2="DrugDDI.d32.s5.e2" interaction="false"/></sentence><sentence id="DrugDDI.d32.s6" origId="s6" text="Furosemide may add to or potentiate the therapeutic effect of other antihypertensive drugs."><entity id="DrugDDI.d32.s6.e0" origId="s6.p60" charOffset="0-10" type="drug" text="Furosemide"/><entity id="DrugDDI.d32.s6.e1" origId="s6.p67" charOffset="68-90" type="drug" text="antihypertensive drugs"/><pair id="DrugDDI.d32.s6.p0" e1="DrugDDI.d32.s6.e0" e2="DrugDDI.d32.s6.e1" interaction="true"/></sentence><sentence id="DrugDDI.d32.s7" origId="s7" text="Potentiation occurs with ganglionic or peripheral adrenergic blocking drugs."><entity id="DrugDDI.d32.s7.e0" origId="s7.p72" charOffset="50-75" type="drug" text="adrenergic blocking drugs"/></sentence><sentence id="DrugDDI.d32.s8" origId="s8" text="Furosemide may decrease arterial responsiveness to norepinephrine."><entity id="DrugDDI.d32.s8.e0" origId="s8.p73" charOffset="0-10" type="drug" text="Furosemide"/><entity id="DrugDDI.d32.s8.e1" origId="s8.p77" charOffset="51-65" type="drug" text="norepinephrine"/><pair id="DrugDDI.d32.s8.p0" e1="DrugDDI.d32.s8.e0" e2="DrugDDI.d32.s8.e1" interaction="true"/></sentence><sentence id="DrugDDI.d32.s9" origId="s9" text="However, norepinephrine may still be used effectively."><entity id="DrugDDI.d32.s9.e0" origId="s9.p79" charOffset="9-23" type="drug" text="norepinephrine"/></sentence><sentence id="DrugDDI.d32.s10" origId="s10" text="Tablets Simultaneous administration of sucralfate and furosemide tablets may reduce the natriuretic and antihypertensive effects of furosemide."><entity id="DrugDDI.d32.s10.e0" origId="s10.p86" charOffset="39-49" type="drug" text="sucralfate"/><entity id="DrugDDI.d32.s10.e1" origId="s10.p88" charOffset="54-72" type="drug" text="furosemide tablets"/><entity id="DrugDDI.d32.s10.e2" origId="s10.p91" charOffset="88-99" type="drug" text="natriuretic"/><entity id="DrugDDI.d32.s10.e3" origId="s10.p93" charOffset="104-120" type="drug" text="antihypertensive"/><entity id="DrugDDI.d32.s10.e4" origId="s10.p94" charOffset="132-143" type="drug" text="furosemide"/><pair id="DrugDDI.d32.s10.p0" e1="DrugDDI.d32.s10.e0" e2="DrugDDI.d32.s10.e1" interaction="true"/><pair id="DrugDDI.d32.s10.p1" e1="DrugDDI.d32.s10.e0" e2="DrugDDI.d32.s10.e2" interaction="false"/><pair id="DrugDDI.d32.s10.p2" e1="DrugDDI.d32.s10.e0" e2="DrugDDI.d32.s10.e3" interaction="false"/><pair id="DrugDDI.d32.s10.p3" e1="DrugDDI.d32.s10.e0" e2="DrugDDI.d32.s10.e4" interaction="false"/><pair id="DrugDDI.d32.s10.p4" e1="DrugDDI.d32.s10.e1" e2="DrugDDI.d32.s10.e2" interaction="false"/><pair id="DrugDDI.d32.s10.p5" e1="DrugDDI.d32.s10.e1" e2="DrugDDI.d32.s10.e3" interaction="false"/><pair id="DrugDDI.d32.s10.p6" e1="DrugDDI.d32.s10.e1" e2="DrugDDI.d32.s10.e4" interaction="false"/><pair id="DrugDDI.d32.s10.p7" e1="DrugDDI.d32.s10.e2" e2="DrugDDI.d32.s10.e3" interaction="false"/><pair id="DrugDDI.d32.s10.p8" e1="DrugDDI.d32.s10.e2" e2="DrugDDI.d32.s10.e4" interaction="false"/><pair id="DrugDDI.d32.s10.p9" e1="DrugDDI.d32.s10.e3" e2="DrugDDI.d32.s10.e4" interaction="false"/></sentence><sentence id="DrugDDI.d32.s11" origId="s11" text="Patients receiving both drugs should be observed closely to determine if the desired diuretic and/or antihypertensive effect of furosemide is achieved."><entity id="DrugDDI.d32.s11.e0" origId="s11.p98" charOffset="24-29" type="drug" text="drugs"/><entity id="DrugDDI.d32.s11.e1" origId="s11.p104" charOffset="85-93" type="drug" text="diuretic"/><entity id="DrugDDI.d32.s11.e2" origId="s11.p106" charOffset="101-117" type="drug" text="antihypertensive"/><entity id="DrugDDI.d32.s11.e3" origId="s11.p107" charOffset="128-139" type="drug" text="furosemide"/><pair id="DrugDDI.d32.s11.p0" e1="DrugDDI.d32.s11.e0" e2="DrugDDI.d32.s11.e1" interaction="false"/><pair id="DrugDDI.d32.s11.p1" e1="DrugDDI.d32.s11.e0" e2="DrugDDI.d32.s11.e2" interaction="false"/><pair id="DrugDDI.d32.s11.p2" e1="DrugDDI.d32.s11.e0" e2="DrugDDI.d32.s11.e3" interaction="false"/><pair id="DrugDDI.d32.s11.p3" e1="DrugDDI.d32.s11.e1" e2="DrugDDI.d32.s11.e2" interaction="false"/><pair id="DrugDDI.d32.s11.p4" e1="DrugDDI.d32.s11.e1" e2="DrugDDI.d32.s11.e3" interaction="false"/><pair id="DrugDDI.d32.s11.p5" e1="DrugDDI.d32.s11.e2" e2="DrugDDI.d32.s11.e3" interaction="false"/></sentence><sentence id="DrugDDI.d32.s12" origId="s12" text="The intake of furosemide and sucralfate should be separated by at least two hours."><entity id="DrugDDI.d32.s12.e0" origId="s12.p111" charOffset="14-25" type="drug" text="furosemide"/><entity id="DrugDDI.d32.s12.e1" origId="s12.p113" charOffset="29-39" type="drug" text="sucralfate"/><pair id="DrugDDI.d32.s12.p0" e1="DrugDDI.d32.s12.e0" e2="DrugDDI.d32.s12.e1" interaction="true"/></sentence><sentence id="DrugDDI.d32.s13" origId="s13" text="Tablets, Injection, and Oral Solution One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency."><entity id="DrugDDI.d32.s13.e0" origId="s13.p126" charOffset="101-112" type="drug" text="furosemide"/><entity id="DrugDDI.d32.s13.e1" origId="s13.p128" charOffset="116-136" type="drug" text="acetylsalicylic acid"/><pair id="DrugDDI.d32.s13.p0" e1="DrugDDI.d32.s13.e0" e2="DrugDDI.d32.s13.e1" interaction="true"/></sentence><sentence id="DrugDDI.d32.s14" origId="s14" text="There are case reports of patients who developed increased BUN, serum creatinine and serum potassium levels, and weight gain when furosemide was used in conjunction with NSAIDs."><entity id="DrugDDI.d32.s14.e0" origId="s14.p145" charOffset="130-140" type="drug" text="furosemide"/><entity id="DrugDDI.d32.s14.e1" origId="s14.p148" charOffset="170-176" type="drug" text="NSAIDs"/><pair id="DrugDDI.d32.s14.p0" e1="DrugDDI.d32.s14.e0" e2="DrugDDI.d32.s14.e1" interaction="true"/></sentence><sentence id="DrugDDI.d32.s15" origId="s15" text="Literature reports indicate that coadministration of indomethacin may reduce the natriuretic and antihypertensive effects of furosemide in some patients by inhibiting prostaglandin synthesis."><entity id="DrugDDI.d32.s15.e0" origId="s15.p152" charOffset="53-65" type="drug" text="indomethacin"/><entity id="DrugDDI.d32.s15.e1" origId="s15.p155" charOffset="81-92" type="drug" text="natriuretic"/><entity id="DrugDDI.d32.s15.e2" origId="s15.p157" charOffset="97-113" type="drug" text="antihypertensive"/><entity id="DrugDDI.d32.s15.e3" origId="s15.p158" charOffset="125-136" type="drug" text="furosemide"/><entity id="DrugDDI.d32.s15.e4" origId="s15.p160" charOffset="167-180" type="drug" text="prostaglandin"/><pair id="DrugDDI.d32.s15.p0" e1="DrugDDI.d32.s15.e0" e2="DrugDDI.d32.s15.e1" interaction="false"/><pair id="DrugDDI.d32.s15.p1" e1="DrugDDI.d32.s15.e0" e2="DrugDDI.d32.s15.e2" interaction="false"/><pair id="DrugDDI.d32.s15.p2" e1="DrugDDI.d32.s15.e0" e2="DrugDDI.d32.s15.e3" interaction="true"/><pair id="DrugDDI.d32.s15.p3" e1="DrugDDI.d32.s15.e0" e2="DrugDDI.d32.s15.e4" interaction="false"/><pair id="DrugDDI.d32.s15.p4" e1="DrugDDI.d32.s15.e1" e2="DrugDDI.d32.s15.e2" interaction="false"/><pair id="DrugDDI.d32.s15.p5" e1="DrugDDI.d32.s15.e1" e2="DrugDDI.d32.s15.e3" interaction="false"/><pair id="DrugDDI.d32.s15.p6" e1="DrugDDI.d32.s15.e1" e2="DrugDDI.d32.s15.e4" interaction="false"/><pair id="DrugDDI.d32.s15.p7" e1="DrugDDI.d32.s15.e2" e2="DrugDDI.d32.s15.e3" interaction="false"/><pair id="DrugDDI.d32.s15.p8" e1="DrugDDI.d32.s15.e2" e2="DrugDDI.d32.s15.e4" interaction="false"/><pair id="DrugDDI.d32.s15.p9" e1="DrugDDI.d32.s15.e3" e2="DrugDDI.d32.s15.e4" interaction="false"/></sentence><sentence id="DrugDDI.d32.s16" origId="s16" text="Indomethacin may also affect plasma renin levels, aldosterone excretion, and renin profile evaluation."><entity id="DrugDDI.d32.s16.e0" origId="s16.p161" charOffset="0-12" type="drug" text="Indomethacin"/><entity id="DrugDDI.d32.s16.e1" origId="s16.p166" charOffset="50-61" type="drug" text="aldosterone"/><entity id="DrugDDI.d32.s16.e2" origId="s16.p168" charOffset="77-83" type="drug" text="renin"/><pair id="DrugDDI.d32.s16.p0" e1="DrugDDI.d32.s16.e0" e2="DrugDDI.d32.s16.e1" interaction="true"/><pair id="DrugDDI.d32.s16.p1" e1="DrugDDI.d32.s16.e0" e2="DrugDDI.d32.s16.e2" interaction="false"/><pair id="DrugDDI.d32.s16.p2" e1="DrugDDI.d32.s16.e1" e2="DrugDDI.d32.s16.e2" interaction="false"/></sentence><sentence id="DrugDDI.d32.s17" origId="s17" text="Patients receiving both indomethacin and furosemide should be observed closely to determine if the desired diuretic and/or antihypertensive effect of furosemide is achieved."><entity id="DrugDDI.d32.s17.e0" origId="s17.p172" charOffset="24-36" type="drug" text="indomethacin"/><entity id="DrugDDI.d32.s17.e1" origId="s17.p174" charOffset="41-51" type="drug" text="furosemide"/><entity id="DrugDDI.d32.s17.e2" origId="s17.p180" charOffset="107-115" type="drug" text="diuretic"/><entity id="DrugDDI.d32.s17.e3" origId="s17.p182" charOffset="123-139" type="drug" text="antihypertensive"/><entity id="DrugDDI.d32.s17.e4" origId="s17.p183" charOffset="150-161" type="drug" text="furosemide"/><pair id="DrugDDI.d32.s17.p0" e1="DrugDDI.d32.s17.e0" e2="DrugDDI.d32.s17.e1" interaction="true"/><pair id="DrugDDI.d32.s17.p1" e1="DrugDDI.d32.s17.e0" e2="DrugDDI.d32.s17.e2" interaction="false"/><pair id="DrugDDI.d32.s17.p2" e1="DrugDDI.d32.s17.e0" e2="DrugDDI.d32.s17.e3" interaction="false"/><pair id="DrugDDI.d32.s17.p3" e1="DrugDDI.d32.s17.e0" e2="DrugDDI.d32.s17.e4" interaction="false"/><pair id="DrugDDI.d32.s17.p4" e1="DrugDDI.d32.s17.e1" e2="DrugDDI.d32.s17.e2" interaction="false"/><pair id="DrugDDI.d32.s17.p5" e1="DrugDDI.d32.s17.e1" e2="DrugDDI.d32.s17.e3" interaction="false"/><pair id="DrugDDI.d32.s17.p6" e1="DrugDDI.d32.s17.e1" e2="DrugDDI.d32.s17.e4" interaction="false"/><pair id="DrugDDI.d32.s17.p7" e1="DrugDDI.d32.s17.e2" e2="DrugDDI.d32.s17.e3" interaction="false"/><pair id="DrugDDI.d32.s17.p8" e1="DrugDDI.d32.s17.e2" e2="DrugDDI.d32.s17.e4" interaction="false"/><pair id="DrugDDI.d32.s17.p9" e1="DrugDDI.d32.s17.e3" e2="DrugDDI.d32.s17.e4" interaction="false"/></sentence></document>